780 related articles for article (PubMed ID: 31645765)
1. Pan-cancer whole-genome analyses of metastatic solid tumours.
Priestley P; Baber J; Lolkema MP; Steeghs N; de Bruijn E; Shale C; Duyvesteyn K; Haidari S; van Hoeck A; Onstenk W; Roepman P; Voda M; Bloemendal HJ; Tjan-Heijnen VCG; van Herpen CML; Labots M; Witteveen PO; Smit EF; Sleijfer S; Voest EE; Cuppen E
Nature; 2019 Nov; 575(7781):210-216. PubMed ID: 31645765
[TBL] [Abstract][Full Text] [Related]
2. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
[TBL] [Abstract][Full Text] [Related]
3. Pan-cancer whole-genome comparison of primary and metastatic solid tumours.
Martínez-Jiménez F; Movasati A; Brunner SR; Nguyen L; Priestley P; Cuppen E; Van Hoeck A
Nature; 2023 Jun; 618(7964):333-341. PubMed ID: 37165194
[TBL] [Abstract][Full Text] [Related]
4. Mutational landscape and significance across 12 major cancer types.
Kandoth C; McLellan MD; Vandin F; Ye K; Niu B; Lu C; Xie M; Zhang Q; McMichael JF; Wyczalkowski MA; Leiserson MDM; Miller CA; Welch JS; Walter MJ; Wendl MC; Ley TJ; Wilson RK; Raphael BJ; Ding L
Nature; 2013 Oct; 502(7471):333-339. PubMed ID: 24132290
[TBL] [Abstract][Full Text] [Related]
5. Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations.
Brown D; Smeets D; Székely B; Larsimont D; Szász AM; Adnet PY; Rothé F; Rouas G; Nagy ZI; Faragó Z; Tőkés AM; Dank M; Szentmártoni G; Udvarhelyi N; Zoppoli G; Pusztai L; Piccart M; Kulka J; Lambrechts D; Sotiriou C; Desmedt C
Nat Commun; 2017 Apr; 8():14944. PubMed ID: 28429735
[TBL] [Abstract][Full Text] [Related]
6. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns.
Jiao W; Atwal G; Polak P; Karlic R; Cuppen E; ; Danyi A; de Ridder J; van Herpen C; Lolkema MP; Steeghs N; Getz G; Morris QD; Stein LD;
Nat Commun; 2020 Feb; 11(1):728. PubMed ID: 32024849
[TBL] [Abstract][Full Text] [Related]
7. The clonal and mutational evolution spectrum of primary triple-negative breast cancers.
Shah SP; Roth A; Goya R; Oloumi A; Ha G; Zhao Y; Turashvili G; Ding J; Tse K; Haffari G; Bashashati A; Prentice LM; Khattra J; Burleigh A; Yap D; Bernard V; McPherson A; Shumansky K; Crisan A; Giuliany R; Heravi-Moussavi A; Rosner J; Lai D; Birol I; Varhol R; Tam A; Dhalla N; Zeng T; Ma K; Chan SK; Griffith M; Moradian A; Cheng SW; Morin GB; Watson P; Gelmon K; Chia S; Chin SF; Curtis C; Rueda OM; Pharoah PD; Damaraju S; Mackey J; Hoon K; Harkins T; Tadigotla V; Sigaroudinia M; Gascard P; Tlsty T; Costello JF; Meyer IM; Eaves CJ; Wasserman WW; Jones S; Huntsman D; Hirst M; Caldas C; Marra MA; Aparicio S
Nature; 2012 Apr; 486(7403):395-9. PubMed ID: 22495314
[TBL] [Abstract][Full Text] [Related]
8. Pervasive chromosomal instability and karyotype order in tumour evolution.
Watkins TBK; Lim EL; Petkovic M; Elizalde S; Birkbak NJ; Wilson GA; Moore DA; Grönroos E; Rowan A; Dewhurst SM; Demeulemeester J; Dentro SC; Horswell S; Au L; Haase K; Escudero M; Rosenthal R; Bakir MA; Xu H; Litchfield K; Lu WT; Mourikis TP; Dietzen M; Spain L; Cresswell GD; Biswas D; Lamy P; Nordentoft I; Harbst K; Castro-Giner F; Yates LR; Caramia F; Jaulin F; Vicier C; Tomlinson IPM; Brastianos PK; Cho RJ; Bastian BC; Dyrskjøt L; Jönsson GB; Savas P; Loi S; Campbell PJ; Andre F; Luscombe NM; Steeghs N; Tjan-Heijnen VCG; Szallasi Z; Turajlic S; Jamal-Hanjani M; Van Loo P; Bakhoum SF; Schwarz RF; McGranahan N; Swanton C
Nature; 2020 Nov; 587(7832):126-132. PubMed ID: 32879494
[TBL] [Abstract][Full Text] [Related]
9. Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours.
Ma X; Liu Y; Liu Y; Alexandrov LB; Edmonson MN; Gawad C; Zhou X; Li Y; Rusch MC; Easton J; Huether R; Gonzalez-Pena V; Wilkinson MR; Hermida LC; Davis S; Sioson E; Pounds S; Cao X; Ries RE; Wang Z; Chen X; Dong L; Diskin SJ; Smith MA; Guidry Auvil JM; Meltzer PS; Lau CC; Perlman EJ; Maris JM; Meshinchi S; Hunger SP; Gerhard DS; Zhang J
Nature; 2018 Mar; 555(7696):371-376. PubMed ID: 29489755
[TBL] [Abstract][Full Text] [Related]
10. The evolutionary history of lethal metastatic prostate cancer.
Gundem G; Van Loo P; Kremeyer B; Alexandrov LB; Tubio JMC; Papaemmanuil E; Brewer DS; Kallio HML; Högnäs G; Annala M; Kivinummi K; Goody V; Latimer C; O'Meara S; Dawson KJ; Isaacs W; Emmert-Buck MR; Nykter M; Foster C; Kote-Jarai Z; Easton D; Whitaker HC; ; Neal DE; Cooper CS; Eeles RA; Visakorpi T; Campbell PJ; McDermott U; Wedge DC; Bova GS
Nature; 2015 Apr; 520(7547):353-357. PubMed ID: 25830880
[TBL] [Abstract][Full Text] [Related]
11. The patterns and dynamics of genomic instability in metastatic pancreatic cancer.
Campbell PJ; Yachida S; Mudie LJ; Stephens PJ; Pleasance ED; Stebbings LA; Morsberger LA; Latimer C; McLaren S; Lin ML; McBride DJ; Varela I; Nik-Zainal SA; Leroy C; Jia M; Menzies A; Butler AP; Teague JW; Griffin CA; Burton J; Swerdlow H; Quail MA; Stratton MR; Iacobuzio-Donahue C; Futreal PA
Nature; 2010 Oct; 467(7319):1109-13. PubMed ID: 20981101
[TBL] [Abstract][Full Text] [Related]
12. Comparative genomic analysis of primary and synchronous metastatic colorectal cancers.
Lee SY; Haq F; Kim D; Jun C; Jo HJ; Ahn SM; Lee WS
PLoS One; 2014; 9(3):e90459. PubMed ID: 24599305
[TBL] [Abstract][Full Text] [Related]
13. Whole genome sequencing analysis for cancer genomics and precision medicine.
Nakagawa H; Fujita M
Cancer Sci; 2018 Mar; 109(3):513-522. PubMed ID: 29345757
[TBL] [Abstract][Full Text] [Related]
14. High-depth sequencing of paired primary and metastatic tumours: Implications for personalised medicine.
Grellety T; Lucchesi C; Hostein I; Auzanneau C; Khalifa E; Soubeyran I; Italiano A
Eur J Cancer; 2017 Oct; 84():250-256. PubMed ID: 28841542
[TBL] [Abstract][Full Text] [Related]
15. Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages.
Yang M; Topaloglu U; Petty WJ; Pagni M; Foley KL; Grant SC; Robinson M; Bitting RL; Thomas A; Alistar AT; Desnoyers RJ; Goodman M; Albright C; Porosnicu M; Vatca M; Qasem SA; DeYoung B; Kytola V; Nykter M; Chen K; Levine EA; Staren ED; D'Agostino RB; Petro RM; Blackstock W; Powell BL; Abraham E; Pasche B; Zhang W
J Hematol Oncol; 2017 May; 10(1):100. PubMed ID: 28472989
[TBL] [Abstract][Full Text] [Related]
16. Mutation-Attention (MuAt): deep representation learning of somatic mutations for tumour typing and subtyping.
Sanjaya P; Maljanen K; Katainen R; Waszak SM; ; Aaltonen LA; Stegle O; Korbel JO; Pitkänen E
Genome Med; 2023 Jul; 15(1):47. PubMed ID: 37420249
[TBL] [Abstract][Full Text] [Related]
17. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.
Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
[No Abstract] [Full Text] [Related]
18. Divergent mutational processes distinguish hypoxic and normoxic tumours.
Bhandari V; Li CH; Bristow RG; Boutros PC;
Nat Commun; 2020 Feb; 11(1):737. PubMed ID: 32024819
[TBL] [Abstract][Full Text] [Related]
19. Seeking the driver in tumours with apparent normal molecular profile on comparative genomic hybridization and targeted gene panel sequencing: what is the added value of whole exome sequencing?
Postel-Vinay S; Boursin Y; Massard C; Hollebecque A; Ileana E; Chiron M; Jung J; Lee JS; Balogh Z; Adam J; Vielh P; Angevin E; Lacroix L; Soria JC
Ann Oncol; 2016 Feb; 27(2):344-52. PubMed ID: 26598538
[TBL] [Abstract][Full Text] [Related]
20. Recurrent somatic mutations reveal new insights into consequences of mutagenic processes in cancer.
Stobbe MD; Thun GA; Diéguez-Docampo A; Oliva M; Whalley JP; Raineri E; Gut IG
PLoS Comput Biol; 2019 Nov; 15(11):e1007496. PubMed ID: 31765368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
